Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-1502 spray in adult scalp seborrheic dermatitis (adaptive phase II/III)
CTR20241761Phase 3Active
- Sponsor
- Zedman Pharma
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TAP-1502 in seborrheic dermatitis (SD), sponsored by Zedman Pharma. Started Jul 2024; status: active.
02
Drugs
TAP-1502
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on CTR20241761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241761.